894 studies found for:    "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Unknown  Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
22 Terminated Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ablation of hepatocellular carcinoma
23 Enrolling by invitation Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Device: Arsenic trioxide TACE;   Drug: Arsenic trioxide intravenous infusion;   Drug: lipiodol;   Drug: NaCl solution
24 Completed Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
25 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
26 Active, not recruiting TRC105 for Liver Cancer That Has Not Responded to Sorafenib
Conditions: Hepatocellular Carcinoma;   Hepatocellular Cancer;   Carcinoma, Hepatocellular
Intervention: Drug: TRC105
27 Recruiting Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Subjects With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: MSC2156119J;   Drug: Sorafenib
28 Recruiting Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: Proton Beam Radiotherapy;   Drug: Sorafenib
29 Unknown  Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
Conditions: Advanced Hepatocellular Carcinoma;   Carcinoma;   Carcinoma, Hepatocellular;   Liver Neoplasms;   Neoplasms
Interventions: Drug: Sorafenib with Low-dose FP;   Drug: Sorafenib
30 Completed A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Condition: Carcinoma, Hepatocellular
Intervention: Biological: GV1001
31 Not yet recruiting TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Carcinoma, Hepatocellular
Interventions: Procedure: TACE;   Drug: sorafenib combined with TACE
32 Unknown  Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ethanol instillation (PEI)
33 Not yet recruiting Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Liver Neoplasms;   Carcinoma, Hepatocellular;   Digestive System Neoplasms;   Neoplasms by Site;   Liver Diseases;   Adenocarcinoma;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction];   HBV
Interventions: Procedure: Transarterial Chemoembolization (TACE);   Other: Sorafenib in combination with TACE
34 Completed
Has Results
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin;   Drug: Doxorubicin/Placebo
35 Active, not recruiting Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Liver Dysfunction
Interventions: Drug: Gd-EOB-DTPA;   Procedure: MRI
36 Completed
Has Results
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
37 Completed Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Somatostatin (octreotide)
38 Active, not recruiting Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Mapatumumab;   Drug: Placebo;   Drug: Sorafenib
39 Unknown  A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: JX-594 followed by sorafenib
40 Recruiting c-Met Second-Line Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: MSC2156119J

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years